TACR1 and neoplasm: SP also promotes the expression of degradative enzymes (matrix metalloproteinases) favoring tumor cell migration, invasion, and metastasis [43, 56], whereas NK-1R antagonists block tumor cell proliferation, migration, and invasion [55].